1. bookTom 57 (2018): Zeszyt 2 (January 2018)
Informacje o czasopiśmie
Pierwsze wydanie
01 Mar 1961
Częstotliwość wydawania
4 razy w roku
Angielski, Polski
Otwarty dostęp

Gammaherpesviral infections in patients with immunological disorders

Data publikacji: 23 May 2019
Tom & Zeszyt: Tom 57 (2018) - Zeszyt 2 (January 2018)
Zakres stron: 145 - 155
Otrzymano: 01 Oct 2017
Przyjęty: 01 Jan 2018
Informacje o czasopiśmie
Pierwsze wydanie
01 Mar 1961
Częstotliwość wydawania
4 razy w roku
Angielski, Polski

Ablashi D.V., Chatlynne L.G., Whitman J.E. Jr, Cesarman E.: Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin. Microbiol. Rev. 15, 439–464 (2002)Search in Google Scholar

Achenbach C.J., Harrington R.D., Dhanireddy S., Crane H.M., Casper C., Kitahata M.M.: Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin. Infect. Dis. 54, 424–433 (2012)Search in Google Scholar

Adamczyk K., Byczkowska K., Kowalska-Piaskowska A., Mozer- -Lisewska I.: Zakażenia wywołane przez wirusy z rodziny Her- pesviridae u osób HIV dodatnich. Now. Lek.79, 474–478 (2010)Search in Google Scholar

Andersson J.: Epstein-Barr virus and Hodgkin’s lymphoma. Herpes, 13, 12–16 (2006)Search in Google Scholar

Aozasa K., Zaki MA.: Epidemiology and pathogenesis of nasal NK/T-cell lymphoma: a mini-review. ScientificWorld Journal. 11, 422–428 (2011)10.1100/tsw.2011.41572001721336457Search in Google Scholar

Bornkamm GW.: Epstein-Barr virus and the pathogenesis of Burkitt’s lymphoma: more questions than answers. Int. J. Cancer. 124, 1745–1755 (2009)Search in Google Scholar

Bower M., Nelson M., Young A.M., Thirlwell C., Newsom-Davis T., Mandalia S., Dhillon T., Holmes P., Gazzard B.G., Steb- bing J.: Immune reconstitution inflammatory syndrome associated with Kaposi’s sarcoma. J. Clin. Oncol. 23, 5224–5228 (2005)Search in Google Scholar

Braun-Falco O., Plewig G., Wolff H., Burgdorf W. (red.). Dermatology. Wyd. 2. Springer Verlag, Berlin-Heidelberg, 2000, s. 1486–148810.1007/978-3-642-97931-6Search in Google Scholar

Braz-Silva P.H., de Rezende N.P., Ortega K.L., de Macedo Santos R.T., de Magalhães M.H.: Detection of the Epstein-Barr virus (EBV) by in situ hybridization as definitive diagnosis of hairy leukoplakia. Head Neck Pathol.2, 19–24 (2008)10.1007/s12105-007-0039-9280760820614337Search in Google Scholar

Brinkmann M.M., Pietrek M., Dittrich-Breiholz O., Kracht M., Schulz T.F.: Modulation of host gene expression by the K15 protein of kaposi’s sarcoma-associated herpesvirus. J. Virol.81, 42–58 (2007)10.1128/JVI.00648-06179725617050609Search in Google Scholar

Campo E., Swerdlow S.H., Harris N.L., Pileri S., Stein H., Jaffe E.S.. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood, 117, 5019–5032 (2011)10.1182/blood-2011-01-293050310952921300984Search in Google Scholar

Carbone A., Gloghini A.: AIDS-related lymphomas: from pathogenesis to pathology. Br. J. Haematol. 130, 662–670 (2005)10.1111/j.1365-2141.2005.05613.x16115121Search in Google Scholar

Carbone A., Gloghini A., Caruso A., De Paoli P., Dolcetti R.: The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis. Int. J. Cancer. 140, 1233–1245 (2017)Search in Google Scholar

Cattani P., Cerimele F., Porta D., Graffeo R., Ranno S., Marchetti S., Ricci R., Capodicasa N., Fuga L., Amico R., Cherchi G., Gazzilli M., Zanetti S., Fadda G.: Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions. Clin. Microbiol. Infect.9, 274–279 (2003)10.1046/j.1469-0691.2003.00490.x12667236Search in Google Scholar

Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles DM.: Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186–1191 (1995)Search in Google Scholar

Cesarman E., Mesri E.A.: Virus-associated lymphomas. Curr. Opin. Oncol.11, 322–332 (1999)10.1097/00001622-199909000-0000210505767Search in Google Scholar

Cesarman E.: Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett. 305, 163–174 (2011)10.1016/j.canlet.2011.03.003374254721493001Search in Google Scholar

Cesarman E.: Gammaherpesviruses and lymphoproliferative disorders. Annu. Rev. Pathol. 9, 349–372 (2014)Search in Google Scholar

Chaigne-Delalande B., Lenardo M.J. i wsp: Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science, 341, 186–191 (2013)10.1126/science.1240094389478223846901Search in Google Scholar

Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles DM., Moore P.S.: Identification of herpesvirus-like DNA sequence in AIDS-associated KS. Science, 266, 1865–1869 (1994)10.1126/science.7997879Search in Google Scholar

Clavies A., Tiemann M., Wagner H-J., Dreger P., Suttorp M.: Epstein-Barr virus-associated post-transplant lymphoprolife- -rative disease after bone marrow transplantation mimicking graft-versus-host disease. Pediatr. Transplant. 4, 151–155 (2000)Search in Google Scholar

Connick E., Kane M.A., White I.E., Ryder J., Campbell T.B.: Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin. Infect. Dis. 39, 1852–1855 (2004)Search in Google Scholar

Cote TR, Manns A, Hardy CR i wsp.: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J. Natl. Cancer Inst.88, 675–679 (1996)10.1093/jnci/88.10.675Search in Google Scholar

Crane G.M., Ambinder R.F., Shirley C.M., Fishman E.K., Kasa- mon Y.L., Taube J.M., Borowitz M.J., Duffield A.S.: HHV-8-po- sitive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. Am. J. Surg. Pathol. 38, 426–432 (2014)Search in Google Scholar

Davi F., Raphaёl M. i wsp.: Burkitt-like lymphomas in AIDS patients: Characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin’s lymphomas. Burkitt’s Lymphoma Study Group. J. Clin. Oncol.16, 3788–3795 (1998)Search in Google Scholar

De Paoli P., Carbone A.: Kaposi’s Sarcoma Herpesvirus: twenty years after its discovery. Eur. Rev. Med. Pharmacol. Sci.20, 1288–1294 (2016)Search in Google Scholar

Dow D.E., Cunningham C.K., Buchanan A.M.: A Review of human herpesvirus 8, the Kaposi’s sarcoma-associated herpesvirus, in the pediatric population. J. Pediatric. Infect. Dis. Soc. 3, 66–76 (2014)Search in Google Scholar

Dupin N., Escande J.P. i wsp.: The influence of highly active antiretroviral therapy on AIDS-associated Kaposi’s sarcoma. Br. J. Dermatol.140, 875–881 (1999)Search in Google Scholar

Durandy A., Sutton L., Bordigoni P., Garnier J., Bidois J., Deist F., Blanche S., Fischer A.: Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood, 92, 3137–3147 (1998)10.1182/blood.V92.9.3137.421k28_3137_3147Search in Google Scholar

Ebell M.H.: Epstein-Barr virus infectious mononucleosis. Am. Fam. Physician. 70, 1279–1287 (2004)Search in Google Scholar

Ensoli B., Barillari G., Salahuddin S.Z.: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients. Nature,345, 84–86 (1990)10.1038/345084a0Search in Google Scholar

Emuss V., Lagos D., Pizzey A., Gratrix F., Henderson S.R., Boshoff C.: KSHV manipulates notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog. 5, e100016 (2009)10.1371/journal.ppat.1000616Search in Google Scholar

Epstein M.A., Barr Y.M., Achong B.G.: A second virus-carrying tissue culture strain (EB2) of lymphoblasts from Burkitt’s lymphoma. Pathol. Biol. 12, 1233–1234 (1964)Search in Google Scholar

Epstein M.A., Henle G., Achong B.G., Barr Y.M.: Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt’s lymphoma. J. Exp. Med.121, 761–770 (1965)10.1084/jem.121.5.761Search in Google Scholar

Filipovich A.H., Zhang K., Snow A.L., Marsh R.A.: X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood,116, 3398–3408 (2010)10.1182/blood-2010-03-275909Search in Google Scholar

Fujii T., Taguchi H., Katano H., Mori S., Nakamura T., Nojiri N., Nakajima K., Tadokoro K., Juji T., Iwamoto A.: Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan. J. Med. Virol.57, 159–162 (1999)10.1002/(SICI)1096-9071(199902)57:2<159::AID-JMV12>3.0.CO;2-ASearch in Google Scholar

Geng L., Wang X.: Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments. Int. J. Clin. Exp. Med. 8,14656–14671 (2015)Search in Google Scholar

Ghosh S., Bienemann K., Boztug K., Borkhardt A.: Interleu- kin-2-inducible T-cell kinase (ITK) deficiency – clinical and molecular aspects. J. Clin. Immunol. 34, 892–899 (2014)Search in Google Scholar

Görzer I., Niesters H.G., Cornelissen J.J., Puchhammer-Stöckl E.: Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Res. 118, 105–114 (2006)10.1016/j.virusres.2005.11.020Search in Google Scholar

Gramolelli S., Schulz TF.: The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. J. Pathol. 235, 368–380 (2015)10.1002/path.4441Search in Google Scholar

Grulich A.E., Vajdic C.M.: The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin. Oncol.42, 247–257 (2015)10.1053/j.seminoncol.2014.12.029Search in Google Scholar

Hardie DR.: Human gamma-herpesviruses: a review of 2 divergent paths to oncogenesis. Transfus. Apher. Sci. 42, 177–183 (2014)Search in Google Scholar

zur Hausen H.: Epstein-Barr virus. (w) Infections Causing Human Cancer. Wiley-VCH Verlag, Weinhem, 2006, s. 65–9510.1002/3527609318Search in Google Scholar

Hengge U., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., Seeber S.: Update on Kaposi’s sarcoma and other HHV-8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations and therapy. Lancet Infect. Dis.2, 281–292 (2002)10.1016/S1473-3099(02)00263-3Search in Google Scholar

Henke-Gendo C., Viejo-Borbolla A., Schulz T.F.: Kaposi’s sar- koma-associated herpesvirus (Human herpesvirus 8) (w) Principles and practice of clinical virology, red. A.J. Zuckerman, J.E. Banatvala, B.D. Schoub, P.D. Griffiths, P. Mortimer, Willey-Blackwell, Oxford, 2009, s. 245–26110.1002/9780470741405.ch11Search in Google Scholar

Heslop HE.: How I treat EBV lymphoproliferation. Blood, 114,4002–4008 (2009)10.1182/blood-2009-07-143545277454019724053Search in Google Scholar

Hladik W., Pellett P.E., Hancock J., Downing R., Gao H., Pac- kel L., Mimbe D., Nzaro E., Mermin J.: Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality. J. Infect. Dis. 1206, 1497–1503 (2012)Search in Google Scholar

Jędrzejczak W.W.: Limfohistiocytoza hemofagocytarna – rzad- ko rozpoznawany uleczalny stan bezpośredniego zagrożenia życia występujący również u dorosłych. Acta Haematol. Pol. 38, 515–526 (2008)Search in Google Scholar

Kalinova L., Indrakova J., Bachleda P.: Post-transplant lymphoproliferative disorder. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 153, 251–257 (2009)10.5507/bp.2009.04320208963Search in Google Scholar

Karst J., Konopka L.: Poprzeszczepowa choroba limfoprolifera- cyjna. Onkol. Pol. 8, 209–216 (2005)Search in Google Scholar

Kieff E., Rickinson A.B.: Epstein-Barr virus and its replication. (w) Fields Virology, wyd. 4, red. Fields B.N., Knipe D.M., Howley P. Philadelphia, PA: Lippincott Williams& Wilkins, 2001, s. 2511–2575Search in Google Scholar

Kim H.J., Huh J. i in.: Hematopathology Study Group of the Korean Society of Pathologists. Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification. J. Pathol. Transl. Med. 51, 352–358 (2017)Search in Google Scholar

Klein G.: Perspectives in studies of human tumor viruses. Front. Biosci.7, 268–274 (2002)10.2741/A72611779700Search in Google Scholar

Klepfish A., Zuckermann B., Schattner A.: Primary effusion lymphoma in the absence of HIV infection – clinical presentation and management. QJM. 108, 481–488 (2015)10.1093/qjmed/hcu23225413797Search in Google Scholar

Kleynberg R.L., Schiller G.J.: Secondary hemophagocytic lym- phohistiocytosis in adults: an update on diagnosis and therapy. Clin. Adv. Hematol. Oncol. 10, 726–732 (2012)Search in Google Scholar

Knowles D.M., Inghirami G., Ubriaco A., Dalla-Favera R.: Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood. 73, 792–799 (1989)10.1182/blood.V73.3.792.bloodjournal733792Search in Google Scholar

Kotlarek-Haus S., Haus O.: Chłoniaki u osób zakażonych HIV. Acta. Haematol. Pol. 31, 249–258 (2000)Search in Google Scholar

Larocca L.M., Gaidano G., i wsp.: The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histoge- netic derivation from germinal center-related B cells. Blood. 92, 1011–1019 (1998)Search in Google Scholar

Levine A.M., Tulpule A.: Clinical aspects and management of AIDS-related Kaposi’s sarcoma. Eur. J. Cancer. 37, 1288–1295 (2001)Search in Google Scholar

Li F.Y., Chaigne-Delalande B., Kanellopoulou C., Davis J.C., Matthews H.F., Douek D.C., Cohen J.I., Uzel G., Su H.C., Lenardo M.J.: Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature,475, 471–476 (2011)10.1038/nature10246315956021796205Search in Google Scholar

Liu M., Liu B., Liu B., Wang Q., Ding L., Xia C., Dong L.: Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases. Oncol. Rep.33, 1615– 1620 (2015)10.3892/or.2015.3808Search in Google Scholar

Luppi M., Barozzi P., Schulz T.F., Setti G., Staskus K., Trovato R., Narni F., Donelli A., Maiorana A., Marasca R., Sandrini S., Torelli G.: Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N. Engl. J. Med. 343, 1378–1385 (2000)Search in Google Scholar

Machaczka M.: Limfohistiocytoza hemofagocytarna – współ- czesny problem medyczny. Pol. Merk. Lek.187, 59–63 (2012)Search in Google Scholar

Machowicz R., Drozd-Sokołowska J., Zduńczyk D., Górnicka B., Boguradzki P., Jędrzejczak W.: Limfohistiocytoza hemofagocy- tarna (HLH) indukowana przez chłoniaka – opis przypadku. OncoReview,1, 304–307 (2011)Search in Google Scholar

Marsh R.A., Madden L., Kitchen B.J., Mody R., McClimon B., Jordan M.B., Bleesing J.J., Zhang K., Filipovich A.H.: XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood,116, 1079–1082 (2010)10.1182/blood-2010-01-256099Search in Google Scholar

Martin D., Galisteo R., Molinolo A.A., Wetzker R., Hirsch E., Gutkind J.S.: PI3Kgamma mediates kaposi’s sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis. Cancer Cell,19, 805–813 (2011)10.1016/j.ccr.2011.05.005Search in Google Scholar

Mckee P.H., Calonje E., Granter S.R.: Pathology of the skin with clinical correlations. Elsevier Mosby, London, 2006, s. 1830– 1836.Search in Google Scholar

Minhas V., Wood C.: Epidemiology and transmission of Kaposi’s sarcoma-associated herpesvirus. Viruses. 6, 4178–94 (2014)10.3390/v6114178Search in Google Scholar

Mularoni A., Conaldi P.G. i wsp.: Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations with the Human Herpesvirus 8 miRNome and Specific T Cell Response. Am. J. Transplant. doi: 10.1111/ajt.14346 (2017)10.1111/ajt.14346Search in Google Scholar

Münz C., Moormann A.: Immune escape by Epstein-Barr virus associated malignancies. Semin. Cancer. Biol. 18, 381–387 (2008)Search in Google Scholar

Mutlu A.D., Mesri E.A. i wsp.: In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: A cell and animal model of virally induced kaposi’s sarcoma. Cancer Cell,11, 245–258 (2007)10.1016/j.ccr.2007.01.015Search in Google Scholar

Neparidze N., Lacy J.: Malignancies associated with Epstein-Barr virus: pathobiology, clinical features, and evolving treatments. Clin. Adv. Hematol. Oncol.12, 358–371 (2014)Search in Google Scholar

Newlon J.L., Couch M., Brennan J.: Castleman’s disease: three case reports and a review of the literature. Ear Nose Throat J. 86, 414–418 (2007)10.1177/014556130708600721Search in Google Scholar

Oksenhendler E., Cazals-Hatem D., Schulz T.F., Barateau V., Grollet L., Sheldon J., Clauvel J.P., Sigaux F., Agbalika F.: Transient angiolymphoid hyperplasia and Kaposi’s sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N. Engl. J. Med.338, 1585–1590 (1998)10.1056/NEJM199805283382204Search in Google Scholar

Palac-Siczek M., Pierniczka-Załęska M., Borowska K.: Ograni- czona choroba Castlemana o łagodnym przebiegu klinicznym – opis przypadku. Otolaryngol. Pol.65, 108–111 (2011)10.1016/S0030-6657(11)70666-7Search in Google Scholar

Pierangeli A., Antonelli G., Gentile G.: Immunodeficiency-associated viral oncogenesis. Clin Microbiol Infect. 21, 975–983 (2015)10.1016/j.cmi.2015.07.00926197213Search in Google Scholar

Polizzotto M.N., Uldrick T.S., Hu D., Yarchoan R.: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome. Front. Microbiol. 3, 73 (2012)10.3389/fmicb.2012.00073Search in Google Scholar

Przybylski M., Dzieciatkowski T., Zduńczyk D., Jędrzejczak W.W., Luczak M.: Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report. Arch. Immunol. Ther. Exp. (Warsz).58, 247–252 (2010)10.1007/s00005-010-0071-4Search in Google Scholar

Purtilo D.T., Cassel C.K., Yang J.P.S., Harper L.: X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet.1, 935–940 (1975)10.1016/S0140-6736(75)92004-8Search in Google Scholar

Purushothaman P., Dabral P., Gupta N., Sarkar R., Verma S.C.: KSHV genome replication and maintenance. Front. Microbiol. 7, 54 (2016)10.3389/fmicb.2016.00054Search in Google Scholar

Ravell J., Chaigne-Delalande B., Lenardo M.: X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect. Curr. Opin. Pediatr. 26, 713–719 (2014)10.1097/MOP.0000000000000156Search in Google Scholar

Reddy N., Rezvani K., Barrett A.J., Savani BN.: Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. Biol. Blood Marrow Transplant. 17, 591–597 (2011)10.1016/j.bbmt.2010.08.007Search in Google Scholar

Lieberman P., Hu J., Renne R.: Gammaherpesvirus maintenance and replication during latency (w) Human Herpesviruses, Biology, Therapy and Immunoprophylaxis, red. Arvin A., Campa- delli-Fiume G., Mocarski E., Moore P.S., Roizman B., Whitley R., Yamanishi K., Cambridge University Press, Cambridge, 2007, s. 379–40310.1017/CBO9780511545313.025Search in Google Scholar

Ruiz-Cordero R.R., Lewis J., Blieden C., Campuzano-Zuluaga G., Hernandez J., Lossos I.S., Ikpatt F., Chapman J.R., Vega F.: Unusual immunophenotypic variant of large B-cell lymphoma associated with HHV-8 and EBV in an HIV positive patient. Human Pathol.: Case Reports.2, 49–54 (2015)10.1016/j.ehpc.2015.02.002Search in Google Scholar

Sarmati L.: HHV-8 infection in African children. Herpes, 11, 2–8 (2004)Search in Google Scholar

Schulz T.: The pleiotropic effects of Kaposi’s sarcoma herpesvirus. J. Path.208, 187–198 (2006)10.1002/path.1904Search in Google Scholar

Schwartzberg P.L., Mueller K.L., Qi H., Cannons J.L.: SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat. Rev. Immunol., 9, 39–46 (2009)Search in Google Scholar

Shu C.H., Chang Y.S., Liang C.L., Liu S.T., Lin C.Z., Chang P.: Distribution of type A and type B EBV in normal individuals and patients with head and neck carcinomas in Taiwan. J. Virol. Methods.38, 123–130 (1992)10.1016/0166-0934(92)90175-DSearch in Google Scholar

da Silva S.R., de Oliveira D.E.: HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. Cancer Lett.305, 175–185 (2011)10.1016/j.canlet.2011.02.00721402436Search in Google Scholar

Simon K., Knysz B., Szybejko-Machaj G., Gładysz A: Mięsak Kaposiego u pacjentów z nabytym zespołem upośledzenia odporności (AIDS) — obserwacje własne. Współcz. Onkol. 1, 21–24 (2000)Search in Google Scholar

Sodhi A., Montaner S., Patel V., Gomez-Roman J.J., Li Y., Sausville E.A., Sawai E.T., Gutkind J.S.: AKT plays a central role in sarcomagenesis induced by kaposi’s sarcoma herpesvirus-encoded g protein-coupled receptor. Proc. Natl. Acad. Sci. USA, 101, 4821–4826 (2004)10.1073/pnas.040083510138733215047889Search in Google Scholar

Soumerai J.D., Sohani A.R., Abramson J.S.: Diagnosis and management of Castleman disease. Cancer Control. 21, 266– 278 (2014)10.1177/10732748140210040325310208Search in Google Scholar

Stojanova J., Caillard S., Rousseau A., Marquet P.: Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants. Pharmacol. Res.63, 1–7 (2011)10.1016/j.phrs.2010.10.01621056103Search in Google Scholar

Sumazaki R., Kanegane H., Osaki M., Fukushima T., Tsu- chida M., Matsukura H., Shinozaki K., Kimura H., Matsui A., Miyawaki T.: SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses. Blood, 98, 1268–1270 (2001)10.1182/blood.V98.4.1268Search in Google Scholar

Tappero J.W., Conant M.A., Wolf S.F., Berger T.G.: Kaposi’s sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J. Am. Acad. Dermatol. 28, 371–395 (1993)Search in Google Scholar

Thompson MP., Kurzrock R.: Epstein-Barr virus and cancer. Clin. Cancer Res. 10, 803–821 (2004)Search in Google Scholar

Thorley-Lawson D.A., Gross A.: Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350, 1328–1337 (2004)Search in Google Scholar

Tserenpuntsag B., Kołacińska A., Jabłonowska E.: Nowotwory związane z AIDS w erze skojarzonego leczenia antyretrowiru- sowego (HAART). Przegl. Epidemiol.61, 529–534 (2007)Search in Google Scholar

Uldrick T.S., Whitby D.: Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett. 305, 150–162 (2011)10.1016/j.canlet.2011.02.006308559221377267Search in Google Scholar

Vereide D., Sugden B.: Proof for EBV’s sustaining role in Burkitt’s lymphomas. Semin. Cancer Biol. 19, 389–393 (2009)10.1016/j.semcancer.2009.07.006278987319628040Search in Google Scholar

Viejo-Borbolla A., Schulz T.F.: Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. AIDS Rev. 5, 222–229 (2003)Search in Google Scholar

Weiss L.M., Epstein-Barr virus and Hodgkin’s disease. Curr. Oncol. Rep. 2, 199–204 (2000)10.1007/s11912-000-0094-911122844Search in Google Scholar

Zhang K., Wakefield E., Marsh R.: Lymphoproliferative Disease, X-Linked. 27.02.2004 [aktualizacja 30.06.2016]. (w) Pagon R.A., Adam M.P., Ardinger H.H. i in. (red.): Gene Reviews®[Internet], University of Washington, Seattle, (1993–2016)Search in Google Scholar

Polecane artykuły z Trend MD

Zaplanuj zdalną konferencję ze Sciendo